馳宏鋅鍺(600497.SH):2020年度申請新增總額不超25億元的融資額度
格隆匯3月20日丨馳宏鋅鍺(600497.SH)公佈,公司第七屆董事會第三次會議召開,審議通過《關於公司2020年度向金融機構申請新增融資額度的預案》;同意公司2020年度在現有融資額度基礎上向相關銀行及非銀行金融機構申請新增總額不超過人民幣25億元的融資額度。
具體融資方式、融資期限、擔保方式、實施時間等按與金融機構最終商定的內容和方式執行。同時提請公司股東大會授權經營層向銀行及非銀行金融機構提供具體融資所需資料,出具有關説明,簽署相關文件,授權有效期為:自公司2019年年度股東大會批准之日起至2020年年度股東大會召開之日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.